Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions
- PMID: 23308155
- PMCID: PMC3538784
- DOI: 10.1371/journal.pone.0053169
Clinical importance of angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusions
Abstract
Objective: To investigate the relationship among angiogenic cytokines, fibrinolytic activity and effusion size in parapneumonic effusion (PPE) and their clinical importance.
Methods: From January 2008 through December 2010, 26 uncomplicated (UPPE) and 38 complicated (CPPE) PPE were studied. Based on chest ultrasonography, there were non-loculated in 30, uni-loculated in 12, and multi-loculated effusions in 22 patients. The effusion size radiological scores, and effusion vascular endothelial growth factor (VEGF), interleukin (IL)-8, plasminogen activator inhibitor type-1 (PAI-1) and tissue type plasminogen activator (tPA) were measured on admission. Treatment outcome and pleural fibrosis, defined as radiological residual pleural thickening (RPT), were assessed at 6-month follow-up.
Results: The effusion size and effusion VEGF, IL-8 and PAI-1/tPA ratio were significantly higher in CPPE than in UPPE, and significantly higher in multi-loculated PPE than in non-locualted and uni-loculated PPE, respectively. VEGF (cutoff value 1975 pg/ml) and IL-8 (cutoff value 1937 pg/ml) seemed best to discriminate between UPPE and CPPE. VEGF, IL-8 and effusion size correlated positively with PAI-1/tPA ratio in both UPPE and CPPE. Moreover, the level of VEGF, but not IL-8, correlated positively with effusion size in all patients (r = 0.79, p<0.001) and in UPPE (r = 0.64, p<0.001) and CPPE (r = 0.71, p<0.001) groups. The patients with higher VEGF or greater effusion were prone to have medical treatment failure (n = 10; VEGF, odds ratio 1.01, p = 0.02; effusion size, odds ratio 1.26, p = 0.01). Additionally, ten patients with RPT had larger effusion size and higher levels of VEGF and PAI-1/tPA ratio than did those without.
Conclusions: In PPE, VEGF and IL-8 levels are valuable to identify CPPE, and higher VEGF level or larger effusion is associated with decreased fibrinolytic activity, development of pleural loculation and fibrosis, and higher risk of medical treatment failure.
Conflict of interest statement
References
-
- Mohammed KA, Nasreen N, Hardwick J, Logie CS, Patterson CE, et al. (2001) Bacterial induction of pleural mesothelial monolayer barrier dysfunction. Am J Physiol Lung Cell Mol Physiol 281: L119–125. - PubMed
-
- Broaddus VC, Boylan AM, Hoeffel JM, Kim KJ, Sadick M, et al. (1994) Neutralization of IL-8 inhibits neutrophil influx in a rabbit model of endotoxin- induced pleurisy. J Immunol 152: 2960–2967. - PubMed
-
- Shetty S, John J, Idell S (2009) Pleural fibrosis. In: Light RW, Lee YCG, editors. Textbook of Pleural Diseases. London: Hodder Arnold. 101–112.
-
- Huang HC, Chang HY, Chen CW, Lee CH, Hsiue TR (1999) Predicting factors for outcome of tube thoracostomy in complicated parapneumonic effusion or empyema. Chest 115: 751–756. - PubMed
-
- Chung CL, Chen CH, Sheu JR, Chen YC, Chang SC (2005) Proinflammatory cytokines, transforming growth factor-β1, and fibrinolytic enzymes in loculated and free-flowing pleural exudates. Chest 128: 690–697. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous